BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35851155)

  • 1. PARP14 is a novel target in STAT6 mutant follicular lymphoma.
    Mentz M; Keay W; Strobl CD; Antoniolli M; Adolph L; Heide M; Lechner A; Haebe S; Osterode E; Kridel R; Ziegenhain C; Wange LE; Hildebrand JA; Shree T; Silkenstedt E; Staiger AM; Ott G; Horn H; Szczepanowski M; Richter J; Levy R; Rosenwald A; Enard W; Zimber-Strobl U; von Bergwelt-Baildon M; Hiddemann W; Klapper W; Schmidt-Supprian M; Rudelius M; Bararia D; Passerini V; Weigert O
    Leukemia; 2022 Sep; 36(9):2281-2292. PubMed ID: 35851155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating STAT6 mutations in follicular lymphoma.
    Yildiz M; Li H; Bernard D; Amin NA; Ouillette P; Jones S; Saiya-Cork K; Parkin B; Jacobi K; Shedden K; Wang S; Chang AE; Kaminski MS; Malek SN
    Blood; 2015 Jan; 125(4):668-79. PubMed ID: 25428220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.
    Rawal S; Chu F; Zhang M; Park HJ; Nattamai D; Kannan S; Sharma R; Delgado D; Chou T; Lin HY; Baladandayuthapani V; Luong A; Vega F; Fowler N; Dong C; Davis RE; Neelapu SS
    J Immunol; 2013 Jun; 190(12):6681-93. PubMed ID: 23686488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma.
    Minskaia E; Maimaris J; Jenkins P; Albuquerque AS; Hong Y; Eleftheriou D; Gilmour KC; Grace R; Moreira F; Grimbacher B; ; Morris EC; Burns SO
    J Clin Immunol; 2023 Oct; 43(7):1611-1622. PubMed ID: 37316763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-ADP ribose polymerase-14 limits severity of allergic skin disease.
    Krishnamurthy P; Da-Silva-Arnold S; Turner MJ; Travers JB; Kaplan MH
    Immunology; 2017 Nov; 152(3):451-461. PubMed ID: 28653395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborator of Stat6 (CoaSt6)-associated poly(ADP-ribose) polymerase activity modulates Stat6-dependent gene transcription.
    Goenka S; Cho SH; Boothby M
    J Biol Chem; 2007 Jun; 282(26):18732-9. PubMed ID: 17478423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
    Siddiqi IN; Friedman J; Barry-Holson KQ; Ma C; Thodima V; Kang I; Padmanabhan R; Dias LM; Kelly KR; Brynes RK; Kamalakaran S; Houldsworth J
    Mod Pathol; 2016 Jun; 29(6):570-81. PubMed ID: 26965583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family.
    Cho SH; Ahn AK; Bhargava P; Lee CH; Eischen CM; McGuinness O; Boothby M
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15972-7. PubMed ID: 21911376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
    Pangault C; Amé-Thomas P; Ruminy P; Rossille D; Caron G; Baia M; De Vos J; Roussel M; Monvoisin C; Lamy T; Tilly H; Gaulard P; Tarte K; Fest T
    Leukemia; 2010 Dec; 24(12):2080-9. PubMed ID: 20944673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment.
    Benoit A; Abraham MJ; Li S; Kim J; Estrada-Tejedor R; Bakadlag R; Subramaniam N; Makhani K; Guilbert C; Tu R; Salaciak M; Klein KO; Coyle KM; Hilton LK; Santiago R; Dmitrienko S; Assouline S; Morin RD; Del Rincon SV; Johnson NA; Mann KK
    Int J Hematol; 2024 Mar; 119(3):275-290. PubMed ID: 38285120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential.
    Watanabe T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).
    Ritz O; Rommel K; Dorsch K; Kelsch E; Melzner J; Buck M; Leroy K; Papadopoulou V; Wagner S; Marienfeld R; Brüderlein S; Lennerz JK; Möller P
    Oncotarget; 2013 Jul; 4(7):1093-102. PubMed ID: 23852366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation.
    Mehrotra P; Riley JP; Patel R; Li F; Voss L; Goenka S
    J Biol Chem; 2011 Jan; 286(3):1767-76. PubMed ID: 21081493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14).
    Schweiker SS; Tauber AL; Sherry ME; Levonis SM
    Mini Rev Med Chem; 2018; 18(19):1659-1669. PubMed ID: 30112992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
    Pesu M; Takaluoma K; Aittomäki S; Lagerstedt A; Saksela K; Kovanen PE; Silvennoinen O
    Blood; 2000 Jan; 95(2):494-502. PubMed ID: 10627454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology.
    Karpathiou G; Papoudou-Bai A; Ferrand E; Dumollard JM; Peoc'h M
    Pathol Res Pract; 2021 Jul; 223():153477. PubMed ID: 33991851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 induces expression of TARC/CCL17 via two STAT6 binding sites.
    Wirnsberger G; Hebenstreit D; Posselt G; Horejs-Hoeck J; Duschl A
    Eur J Immunol; 2006 Jul; 36(7):1882-91. PubMed ID: 16810739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of a synthetic degradation of activated STAT6 by PARP-1 inhibition: roles of poly(ADP-ribosyl)ation, calpains and autophagy.
    Wang J; Ghonim MA; Ibba SV; Luu HH; Aydin Y; Greer PA; Boulares AH
    J Transl Med; 2022 Nov; 20(1):521. PubMed ID: 36348405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.
    Calvo KR; Dabir B; Kovach A; Devor C; Bandle R; Bond A; Shih JH; Jaffe ES
    Blood; 2008 Nov; 112(9):3818-26. PubMed ID: 18682601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation.
    Iwata H; Goettsch C; Sharma A; Ricchiuto P; Goh WW; Halu A; Yamada I; Yoshida H; Hara T; Wei M; Inoue N; Fukuda D; Mojcher A; Mattson PC; Barabási AL; Boothby M; Aikawa E; Singh SA; Aikawa M
    Nat Commun; 2016 Oct; 7():12849. PubMed ID: 27796300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.